Abstract
Treatment of cancer, the disease complex due to uncontrolled tissue growth, is in urgent need for more effective therapeutic modalities. An increasing population age combined with successful development of treatments against a number of important infectious diseases have moved cancer to the forefront of human health problems in developed countries. Tremendous efforts have been made in “the war against cancer,” but an improvement in cure rates comparable to those of most infectious diseases has not materialized. On the other hand, allocation of resources to basic and clinical research has provided extremely important knowledge of the molecular basis for the development of malignant cells and general cellular biology.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lewin B (ed) (1994) Genes V. Oxford University Press, Oxford, pp 1205–1209
Levine AJ, Perry ME, Chang A et al. (1994) The 1993 Walter Hubert Lecture: the role of p53 tumour-suppressor gene in tumorigenesis. Br J Cancer 69:409–416
Riethmüller G, Schneider-Gädicke E, Schlimok G et al. (1994) Randomized trial of monoclonal antibody for adjuvant therapy of resected Duke’s C colorectal carcinoma. Lancet 343:1177–1183
Rosenberg SA, Lotze MT, Muul LM et al. (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine activated killer cells and interleukin-2 or high dose interleukin-2 alone. N Engl J Med 316:889–905
Demetri GD, Spriggs DR, Sherman ML et al. (1989) A phase I trial of recombinant human tumor necrosis factor and interferon-gamma: effects of combination cytokine administration in vivo. J Clin Oncol 7:1545–1553
Thompson JA, Benyunes MC, Bianco JA, Fefer A (1993) Treatment with pentoxifylline and ciprofloxacin reduces the toxicity of high-dose interleukin-2 and lymphokine-activated killer cells. Semin Oncol 20:46–51
Nauts HC, Fowler GA, Bogatko FH (1953) Review of the influence of bacterial infection and of bacterial products (Coley’s toxins) on malignant tumors in man. Acta Med Scand Suppl 276
Starnes CO (1992) Coley’s toxins in perspective. Nature 357:11–12
Michie HR, Manogue KR, Spriggs DR et al. (1988) Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481–1486
Johnson HM, Russell JK, Pontzer CH (1992) Superantigens in human disease. Sci Am 266:42–74
Lienard D, Ewalenko P, Delmotte J-J, Renard N, Lejeune FJ (1992) Highdose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 10:52–60
Han J, Lee J-D, Bibbs L, Ulevitch RJ (1994) A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808–811
Alberts B, Bray D, Lewis J et al. (eds) (1989) Molecular biology of the cell. Garland, New York, p 97
Smith GP (1994) Applied evolution: the progeny of sexual PCR. Nature 370:324–325
Mullen JL (1994) Hypermetabolism and advanced cancer. Ann Surg 219:323–324
Westin T (1990) Ornithine decarboxylase activity in malignant tumours. An experimental and clinical study with reference to cell proliferation and nutrition. Thesis, University of Gothenburg, p 155
Gelin J, Andersson C, Lundholm K (1991) Effects of indomethacin, cytokines and cyclosporin A on tumor growth and the subsequent development of cancer cachexia. Cancer Res 51:880–885
Lundholm K, Hyltander A (1994) Anemia, a promotor behind elevated energy expenditure in cancer patients. First Nordic EPREX (epoetin alfa) symposium on the management of anemia in cancer patients. Cilag Biotech, Stockholm, p 8
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Giercksky, KE., Qvist, H. (1996). Catabolism and Tumor — Could a General Catabolic Reaction Be Useful in Treatment of Solid Tumors?. In: Revhaug, A. (eds) Acute Catabolic State. Update in Intensive Care and Emergency Medicine, vol 21. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-48801-6_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-48801-6_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-48803-0
Online ISBN: 978-3-642-48801-6
eBook Packages: Springer Book Archive